![Abraham Bassan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 31/07/2026
Abraham Bassan was the founder of Aurora Medical Group, Inc., founded in 2012, where the title held was Chief Executive Officer from 2012 to 2014.
Current jobs include President, Chief Executive Officer & Director at Link Cell Therapies, Inc. since 2022; Director at Vedere Bio II, Inc. since 2021; Independent Director at Septerna, Inc. since 2021; Independent Director at Rani Therapeutics Holdings, Inc. since 2025; and Partner at Samsara BioCapital LLC since 2017.
Former jobs include Associate Director-Program Development at Genetix Biotherapeutics, Inc. from 2010 to 2012; Director-Program Biology at Revolution Medicines, Inc. from 2015 to 2017; Director at Cargo Therapeutics, Inc. from 2022 to 2025; Independent Director at Graphite Bio, Inc. from 2020 to 2024; and Associate at Third Rock Ventures LLC from 2009 to 2010.
Education includes a graduate degree from Stanford University conferred in 2008 and an undergraduate degree from Princeton University conferred in 2006.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
SEPTERNA, INC. -.--% | 26/06/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| SEPTERNA, INC. | Director/Miembro de la Junta | 01/11/2021 |
| RANI THERAPEUTICS HOLDINGS, INC. | Director/Miembro de la Junta | 23/10/2025 |
Vedere Bio II, Inc.
 Vedere Bio II, Inc. Miscellaneous Commercial ServicesCommercial Services Develops ocular gene therapy | Director/Miembro de la Junta | 01/04/2021 |
Samsara Biocapital LLC
 Samsara Biocapital LLC Investment ManagersFinance Samsara BioCapital invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and pharmaceuticals. It provides early and later stage capital requirements. | Inversor de Capital Privado | 01/07/2017 |
| Empresas | Cargo | Fin |
|---|---|---|
| CARO THERPAR | Presidente | 01/05/2022 |
| LENZ THERAPEUTICS, INC. | Director/Miembro de la Junta | 01/03/2024 |
| REVOLUTION MEDICINES, INC. | Corporate Officer/Principal | 01/07/2017 |
Aurora Medical Group, Inc.
 Aurora Medical Group, Inc. Miscellaneous Commercial ServicesCommercial Services Functions as a not-for-profit healthcare organization that operates hospitals | Director Ejecutivo | 01/09/2014 |
| GENETIX BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 01/08/2012 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 12 |
|---|---|
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
bluebird bio, Inc.
 bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm focuses on the healthcare. It participates in early stage capital requirements. The firm also acts as lead investor. | Finance |
Aurora Medical Group, Inc.
Aurora Medical Group, Inc. Miscellaneous Commercial ServicesCommercial Services Functions as a not-for-profit healthcare organization that operates hospitals | Commercial Services |
Revolution Medicines, Inc.
 Revolution Medicines, Inc. Pharmaceuticals: OtherHealth Technology Develops new therapies derived from natural products | Health Technology |
Samsara Biocapital LLC
Samsara Biocapital LLC Investment ManagersFinance Samsara BioCapital invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and pharmaceuticals. It provides early and later stage capital requirements. | Finance |
Graphite Bio, Inc.
 Graphite Bio, Inc. BiotechnologyHealth Technology Operates as gene editing company for DNA integrations | Health Technology |
Vedere Bio II, Inc.
Vedere Bio II, Inc. Miscellaneous Commercial ServicesCommercial Services Develops ocular gene therapy | Commercial Services |
Rani Therapeutics Holdings, Inc.
 Rani Therapeutics Holdings, Inc. BiotechnologyHealth Technology Engages in research and development of orally administered biological products | Health Technology |
Cargo Therapeutics, Inc.
 Cargo Therapeutics, Inc. BiotechnologyHealth Technology Engages in generation of adoptive cell therapies for cancer treatment | Health Technology |
Septerna, Inc.
 Septerna, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that discovers and develops G protein-coupled receptor oral small molecule products for the treatment of hypoparathyroidism | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
